Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Trinity Biotech Nabs WHO Approval for Outsourced Manufacturing of Rapid HIV Test

14 September 2026 · By · Wire by Fusion42

Published

14 September 2026

Topic

opportunities

◆ Sectors

Diagnostics

◆ Geography

Global

◆ Source

Read at genomeweb.com →

◆ Verified

Fusion42 · 15 September 2026 · Fusion42 review

Irish diagnostics company Trinity Biotech received World Health Organization approval for outsourced manufacturing of its TrinScreen rapid HIV test, enabling expanded production.

This Wire brief sits within Fusion42's coverage of Diagnostics.

◆ ◆ The Wire takeaway

You can now use WHO-approved outsourced manufacturers for HIV rapid tests, cutting your production barriers and accelerating market entry in multiple regions.

◆ Coverage

1 source · 14 Sep 2026

◆ Related on Wire

◆ Topics

Diagnosticshiv-testwho-approvaloutsourced-manufacturingdiagnosticsregulatory